| Paul Yang, MD, PHD | |
|
3375 Sw Terwilliger Blvd, Portland, OR 97239-4146 | |
| (503) 494-8417 | |
| Not Available |
| Full Name | Paul Yang |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 3375 Sw Terwilliger Blvd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295995264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 6808639-1205 (Utah) | Secondary |
| 207W00000X | Ophthalmology | 246825 (Massachusetts) | Secondary |
| 207W00000X | Ophthalmology | MD160071 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
News Archive
By swapping out one specific hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis. The probes detect and measure reactive oxygen species, which play an important role in disease processes.
The Alliance for the Prudent Use of Antibiotics (APUA) has announced a $1.37 million grant from the Bill & Melinda Gates Foundation, to explore ways of reducing millions of preventable deaths from severe respiratory and diarrheal infections in Africa. This project was announced in conjunction with a colloquium at the annual ICAAC/IDSA meeting warning of increasing antibiotic resistance.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.
People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published today in The Lancet has shown.
People with early schizophrenia are at an increased risk of developing diabetes, even when the effects of antipsychotic drugs, diet and exercise are taken out of the equation, according to an analysis by researchers from King's College London.
› Verified 6 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
By swapping out one specific hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis. The probes detect and measure reactive oxygen species, which play an important role in disease processes.
The Alliance for the Prudent Use of Antibiotics (APUA) has announced a $1.37 million grant from the Bill & Melinda Gates Foundation, to explore ways of reducing millions of preventable deaths from severe respiratory and diarrheal infections in Africa. This project was announced in conjunction with a colloquium at the annual ICAAC/IDSA meeting warning of increasing antibiotic resistance.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.
People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published today in The Lancet has shown.
People with early schizophrenia are at an increased risk of developing diabetes, even when the effects of antipsychotic drugs, diet and exercise are taken out of the equation, according to an analysis by researchers from King's College London.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Yang, MD, PHD 48 W Broadway, N2201, Salt Lake City, UT 84101-2007 Ph: (801) 532-2605 | Paul Yang, MD, PHD 3375 Sw Terwilliger Blvd, Portland, OR 97239-4146 Ph: (503) 494-8417 |
News Archive
By swapping out one specific hydrogen atom for an isotope twice as heavy, researchers have increased the shelf life and detection ability of fluorescent probes that are essential to studying a variety of inflammatory diseases, including cancer and atherosclerosis. The probes detect and measure reactive oxygen species, which play an important role in disease processes.
The Alliance for the Prudent Use of Antibiotics (APUA) has announced a $1.37 million grant from the Bill & Melinda Gates Foundation, to explore ways of reducing millions of preventable deaths from severe respiratory and diarrheal infections in Africa. This project was announced in conjunction with a colloquium at the annual ICAAC/IDSA meeting warning of increasing antibiotic resistance.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with type 2 diabetes and mild renal impairment treated with JANUVIA- (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of hypoglycemia (low blood sugar), and with weight loss instead of weight gain.
People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published today in The Lancet has shown.
People with early schizophrenia are at an increased risk of developing diabetes, even when the effects of antipsychotic drugs, diet and exercise are taken out of the equation, according to an analysis by researchers from King's College London.
› Verified 6 days ago
Amy Ying Tong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 Nw Northrup St, Portland, OR 97209 Phone: 503-227-2020 | |
Sungjae Yang, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3375 Sw Terwilliger Bld, Casey Eye Institue, Portland, OR 97239 Phone: 503-494-5023 | |
Dr. Michael David Straiko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1040 Nw 22nd Ave., Suite 200, Portland, OR 97210 Phone: 503-413-8202 Fax: 503-413-6937 | |
Allison Rebecca Loh, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3375 Sw Terwilliger Blvd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
John Carl Morrison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-418-0843 | |
Adam Marcus Hanif, Ophthalmology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
Mr. John Jah-hyun Koo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 N. Interstate Avenue, Department Of Opthalmology, Portland, OR 97227 Phone: 503-331-6330 Fax: 503-571-5877 |